These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1096219)

  • 21. Sex differences in the subjective effects of oral Δ
    Fogel JS; Kelly TH; Westgate PM; Lile JA
    Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis and alcohol: effects on stimulated car driving.
    Rafaelsen OJ; Bech P; Christiansen J; Christrup H; Nyboe J; Rafaelsen L
    Science; 1973 Mar; 179(4076):920-3. PubMed ID: 4569248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic effect of delta-9-tetrahydrocannabinol.
    Noyes R; Brunk SF; Baram DA; Canter A
    J Clin Pharmacol; 1975; 15(2-3):139-43. PubMed ID: 1091664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of oral Δ
    Walter C; Oertel BG; Felden L; Nöth U; Vermehren J; Deichmann R; Lötsch J
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1579-1587. PubMed ID: 28866743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 30. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.
    Karniol IG; Shirakawa I; Kasinski N; Pfeferman A; Carlini EA
    Eur J Pharmacol; 1974 Sep; 28(1):172-7. PubMed ID: 4609777
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
    Ferraro DP; Grilly DM
    Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
    D'Souza DC; Pittman B; Perry E; Simen A
    Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of delta-9-THC and a water soluble ester of delta-9-THC on schedule-controlled behavior.
    Dykstra LA; McMillan DE; Harris LS
    Pharmacol Biochem Behav; 1975; 3(1):29-32. PubMed ID: 1129353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ
    Newmeyer MN; Swortwood MJ; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 Mar; 63(3):647-662. PubMed ID: 28188235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?
    Kleinloog D; Liem-Moolenaar M; Jacobs G; Klaassen E; de Kam M; Hijman R; van Gerven J
    J Psychopharmacol; 2012 Oct; 26(10):1307-16. PubMed ID: 22596206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
    Dittrich A; Woggon B
    Int Pharmacopsychiatry; 1974; 9(3):138-51. PubMed ID: 4609941
    [No Abstract]   [Full Text] [Related]  

  • 40. Cannabis and temporal disintegration in experienced and naive subjects.
    Casswell S; Marks DF
    Science; 1973 Feb; 179(4075):803-5. PubMed ID: 4567504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.